Related Experiment Video
Updated: May 4, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of
Ali Peirovifar1, Manizheh Mostafa Gharehbaghi1, Parvin Mostafa Gharabaghi1
1Neonatal Intensive Care Unit, Al Zahra Hospital, South Arthesh Street, 513866449, Tabriz, Iran. gharehbaghimm@yahoo.com.
Insights
This study found no significant difference in blood vascular endothelial growth factor (VEGF) or insulin-like growth factor-1 (IGF-1) levels between premature infants with retinopathy of prematurity (ROP) and those without. These findings suggest these specific biomarkers may not be useful indicators for ROP in this age group.
Area of Science:
- Neonatal Medicine
- Ophthalmology
- Biochemistry
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Understanding the biochemical factors involved in ROP is crucial for early detection and intervention.
Purpose of the Study:
- To investigate the levels of vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1) in premature infants with proliferative ROP.
- To compare these levels with those in premature infants without ROP.
Main Methods:
- Blood samples were collected from 71 preterm infants (born ≤32 weeks gestation) 6-8 weeks after birth.
- Infants were categorized into a control group (no ROP) and a study group (proliferative ROP, stage III+).
- VEGF and IGF-1 levels were quantified using enzyme-linked immunosorbent assay (ELISA).
Main Results:
- No significant differences in mean blood IGF-1 levels were observed between the ROP group (18.48 ± 11.79 µg/L) and the control group (16.75 ± 13.74 µg/L).
- Similarly, mean blood VEGF levels did not differ significantly between the ROP group (267.35 ± 103.43 pg/mL) and the control group (237.52 ± 130.92 pg/mL).
- Gestational age and postmenstrual age at sampling were comparable between the groups.
Conclusions:
- Blood IGF-1 and VEGF levels at 6-8 weeks postpartum are not significantly different in premature infants with proliferative ROP compared to those without.
- These biomarkers may not serve as reliable indicators for diagnosing or assessing the severity of ROP at this stage.
Introduction:
Retinopathy of prematurity (ROP) can lead to severe visual impairment. This study was conducted to determine the levels of biochemical mediators (i. e. vascular endothelial growth f actor [ VEGF] and insulin- like growth factor-1 [IGF-1]) in the blood of premature infants with proliferative ROP.
Methods:
Blood samples from 71 preterm infants born at or before 32 weeks of gestation were obtained 6-8 weeks after birth. These infants were classified into two groups according to their eye examination results. The control group consisted of 41 infants who had no evidence of ROP, and the study group consisted of 30 infants with proliferative ROP at stage III or higher. Blood VEGF and IGF-1 levels were measured using enzyme-linked immunosorbent assay.
Results:
The mean gestational ages of the infants at birth were 28.4 ± 1.6 and 28.8 ± 1.6 weeks in the study and control groups, respectively (p = 0.259). The mean postmenstrual age of the infants at the time of blood sampling was 34.9 ± 1.2 weeks in the study group and 34.6 ± 1.3 weeks in the control group (p = 0.339). The mean blood IGF-1 (18.48 ± 11.79 µg/L and 16.75 ± 13.74 µg/L in the study and control groups, respectively; p = 0.580) and VEGF (267.35 ± 103.43 pg/mL and 237.52 ± 130.92 pg/mL in the study and control groups, respectively; p = 0.305) levels of the infants were not significantly different between the two groups.
Conclusion:
At 6-8 weeks after birth, blood IGF-1 and VEGF levels were not found to be significantly different between premature infants with proliferative ROP and those without.
More Related Videos
05:56Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
Published on: January 22, 2020
08:47Whole Mount Immunofluorescent Staining of the Neonatal Mouse Retina to Investigate Angiogenesis In vivo
Published on: July 9, 2013
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Diabetic Retinopathy
Mechanism of Angiogenesis
Development of Blood Vessels
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...